Stockscreener 앱 받기
5.92
3.74%
-0.23
시장 영업 전:
6.09
0.17
+2.87%
Aura Biosciences Inc 주식(AURA)의 최신 뉴스
Aura Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Clinical-Stage Biotech Aura Biosciences Lines Up 3 Key Investor Conferences: What to Expect - Stock Titan
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 37.3% in April - Defense World
(AURA) Proactive Strategies - news.stocktradersdaily.com
Aura Biosciences, Inc. (NASDAQ:AURA) Shares Purchased by JPMorgan Chase & Co. - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Position Increased by Geode Capital Management LLC - Defense World
Oncology’s Most Eligible Unpartnered Assets - insights.citeline.com
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 19.3% in March - Defense World
Vanguard Group Inc. Acquires 112,296 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock By Investing.com - Investing.com India
Aura Biosciences SVP sells $4,924 in stock By Investing.com - Investing.com India
Aura Biosciences executive sells $39,319 in stock By Investing.com - Investing.com Canada
Aura Biosciences executive sells $39,319 in stock - Investing.com Australia
Aura Biosciences SVP sells $4,924 in stock - Investing.com
Aura Biosciences SVP Amy Elazzouzi sells $4,924 in stock - Investing.com
Wellington Management Group LLP Has $1.08 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
American Century Companies Inc. Has $392,000 Stake in Aura Biosciences, Inc. (NASDAQ:AURA) - Defense World
Q1 EPS Estimate for Aura Biosciences Decreased by Analyst - Defense World
Aura Biosciences, Inc. (NASDAQ:AURA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Aura Biosciences stock hits 52-week low at $5.05 - Investing.com Australia
Aura Biosciences stock hits 52-week low at $5.05 By Investing.com - Investing.com South Africa
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential? - Insider Monkey
10 Small Cap Stocks with Huge Upside Potential - Insider Monkey
Aura Biosciences expands board with oncology leader By Investing.com - Investing.com South Africa
Aura Biosciences Appoints Teresa Bitetti To Board - citybiz
Aura Biosciences Announces Appointment Of Teresa Bitetti To Board Of Directors - MarketScreener
Aura Biosciences Expands Board with New Director Appointment - TipRanks
Aura Biosciences expands board with oncology leader - Investing.com
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors - GlobeNewswire
Aura Biosciences stock hits 52-week low at $5.75 amid market challenges By Investing.com - Investing.com South Africa
Aura Biosciences stock hits 52-week low at $5.75 amid market challenges - Investing.com Australia
Are Investors Keen On Selling Holdings In Aura Biosciences Inc (NASDAQ: AURA)? - stocksregister.com
(AURA) Long Term Investment Analysis - news.stocktradersdaily.com
Q1 Earnings Estimate for AURA Issued By HC Wainwright - Defense World
Aura Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Institutional investors may adopt severe steps after Aura Biosciences, Inc.'s (NASDAQ:AURA) latest 20% drop adds to a year losses - Simply Wall St
Aura Biosciences Inc: Promising Clinical Progress and Financial Stability Justify Buy Rating - TipRanks
What is HC Wainwright’s Forecast for AURA Q3 Earnings? - Defense World
Aura Biosciences Stock (AURA) Continues to Slide Despite Promising Clinical Progress - markets.businessinsider.com
US Stocks Likely To Open Mixed: 'Expect Volatility. Buckle Up,' Says Expert - Benzinga
Aura Biosciences price target lowered to $19 from $21 at Citizens JMP - TipRanks
Character Biosciences gains $93m for precision eye disease therapies - Pharmaceutical Technology
Bel-sar shows promising safety, efficacy in NMIBC - Urology Times
Aura Biosciences stock target cut to $19 by JMP Securities - Investing.com UK
Aura Biosciences Reports Progress in Cancer Trials - TipRanks
Aura Biosciences Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
Aura Biosciences stock target raised to $25 by H.C. Wainwright - Investing.com UK
0.39%
3.66%
자본화:
|
볼륨(24시간):